Phase 2 trials are a big deal. Probability of passing Phase 3 is much higher than Phase 2 pending Phase 2 has been passed. So if phase 2s come back positive the market cap should be double at least when taking into consideration future revenues generated, BOTs pipeline of products, the safety profile, possible licensing deals etc. The market is forward looking.
Can't compare OCC, totally different field and life cycle of their business. Their trials are going to take a lot more time and recruitment has been slow. Also OCC has been trading strangely, glad I sold OCC yesterday. Although in saying that it has a lot of potential.
Who knows what will happen upon phase 2 results, this market has been a bit crazy as of late.
Bot Chart, page-2391
-
- There are more pages in this discussion • 11,130 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $551.2M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.3¢ | $2.361M | 6.775M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 1459692 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 71273 | 3 |
View Market Depth
| Last trade - 12.26pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |